The DOI matches its Crossref record.
Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial
Abstract
Aims: Current treatments for interstitial cystitis/bladder pain syndrome (IC/BPS) are usually unsuccessful in achieving long‐term bladder pain relief and irritable symptom improvement. This study investigated the clinical efficacy of platelet‐rich plasma (PRP) intravesical injections on IC/BPS patients refractory to conventional therapies. Methods: Forty patients received four monthly intravesical injections of 10 mL PRP extracted from 50 mL of whole blood. The primary end‐point was Global Response Assessment (GRA) at 3 months after the 4th PRP injection. Secondary endpoints included changes in O'Leary‐Sant symptom score (OSS), visual analog scale (VAS) of pain, daily frequency, nocturia, functional bladder capacity (FBC), maximum flow rate, voided volume, post‐void residual volume (PVR) from baseline to 3 months after the 4th PRP injection. Results: All 40 patients (37 women and 3 men, aged 55.5 ± 11.1 years) completed the four injections and follow‐up visits. GRA improved after the 1st PRP injection and the satisfaction persists till the primary end‐point. The success rate was 45%, 52%, 70%, 70%, and 67.5% after the 1st, 2nd, 3rd, 4th, and 3 months after the 4th PRP injection, respectively. OSS and VAS also significantly decreased. The PVR did not change after repeated PRP injections, FBC increased, frequency, and nocturia were decreased after PRP injections. All patients were free of urinary tract infection or difficulty urinating. Conclusion: The study demonstrated that repeated intravesical injections of autologous PRP can increase bladder capacity and provide IC symptom improvement in patients with IC/BPS refractory to conventional therapy. Autologous PRP injection is safe and effective in selected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary studies have demonstrated that multiple intravesical PRP injections could improve symptoms in 70% of IC/BPS patients [46].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [46]
In the citing paper
“The success rate improved from 45% after the first PRP injection, persisted up to 70% at the primary endpoint, and remained at 67.5% at 3 months after the fourth PRP injection [46].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- 10.1016/S0090-4295(01)01112-8 · DOI
- 10.1002/nau.23284 · DOI · Paper page
- 10.1016/j.urology.2004.10.071 · DOI · Paper page
- 10.1097/01.ju.0000083020.06212.3d · DOI · Paper page
- 10.1016/S0022-5347(17)41029-9 · doi:10.1016/s0022-5347(17)41029-9
- 10.1097/01.ju.0000125139.91203.7a · DOI
- 10.1016/j.juro.2007.10.032 · DOI
- 10.1016/j.urology.2011.09.049 · DOI · Paper page
- 10.1016/j.cellsig.2008.06.004 · DOI
- 10.1371/journal.pone.0198816 · DOI · Paper page
- 10.1111/j.1464-410X.2010.09911.x · DOI · Paper page
- 10.1080/09537104.2018.1430357 · DOI · Paper page
- 10.3109/09537104.2016.1143922 · DOI · Paper page
- 10.1007/s12035-013-8494-7 · DOI
- 10.1111/luts.12212 · doi:10.1111/luts.12212
- Hanno P, 1998, Campbell's Urology, 631
- NIDDK workshop of interstitial cystitis Besthesda Maryland USA 1987Aug 28–29.
- 10.1016/S0090-4295(01)01126-8 · DOI
- 10.1016/j.arthro.2017.11.035 · DOI
- 10.1016/j.urology.2005.07.014 · DOI
- 10.1177/0363546518771076 · DOI
- 10.3389/fnins.2018.00252 · DOI
- Çetinkaya RA, 2018, Platelet‐rich plasma as an additional therapeutic option for infected wounds with multi‐drug resistant bacteria: in vitro antibacterial activity study, Eur J Trauma Emerg Surg
- Zhang XL, 2018, Effects of platelet‐rich plasma on angiogenesis and osteogenesis‐associated factors in rabbits with avascular necrosis of the femoral head, Eur Rev Med Pharmacol Sci, 22, 2143
- 10.1371/journal.pone.0151692 · DOI
- 10.1111/j.1464-410X.2005.05776.x · doi:10.1111/j.1464-410x.2005.05776.x
- 10.1186/scrt218 · DOI · Paper page
- 10.1038/s41598-018-19419-6 · DOI
Cited by
Yu, W.-R., Jhang, J.-F., Jiang, Y.-H., & Kuo, H.-C. (2024) · Biomedicines · doi:10.3390/biomedicines12092051 · Cited by 39
Self-citation
Metadata
- Authors
- Jhang, J., Lin, T., & Kuo, H.
- Affiliations
- Department of Urology Buddhist Tzu Chi General Hospital and Tzu Chi University Hualien Taiwan
- Department of Laboratory Medicine Buddhist Tzu Chi General Hospital and Tzu Chi University Hualien Taiwan
- ORCID
- Kuo, Hann‐Chorng
- Venue
- Neurourology and Urodynamics
- Publisher
- Wiley
- Published
- 2018-12-21
- Volume
- 38
- Issue
- 2
- Pages
- 703-709
- ISSN
- 0733-2467
- 1520-6777
- Cited by
- 47
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.